4-Pyrimidinamine, 5-(Bromomethyl)-2-methyl-, Monohydrobromide Cas 2908-71-6

Table of Contents

• 1. Product Specifications & Comparative Analysis
• 2. Functional Applications
• 3. Operational Protocols
• 4. Industry Case Studies
• 5. Client Success Stories
• 6. Technical Consultation & Quotation

1. Product Specifications & Comparative Analysis

2. Functional Applications

This brominated pyrimidine derivative serves as:

• Key intermediate in kinase inhibitor synthesis
• Building block for anticancer drug candidates
• Cross-linking agent in polymer chemistry
• Precursor for radiopharmaceutical labeling

3. Operational Protocols

Storage: Maintain at 2-8°C under inert atmosphere

Handling: Use PPE including nitrile gloves and chemical goggles

Solubility: 25 mg/mL in DMSO (clear solution at 20°C)

4. Industry Case Studies

Case A: Used in Phase II clinical trial material synthesis for non-small cell lung cancer treatment (2024)

Case B: Enabled 32% yield improvement in antiviral compound production through optimized bromination (2023)

5. Client Success Stories

PharmaCorp Inc. (USA):

• Application: EGFR inhibitor development
• Quantity: 15 kg batch order
• Result: Achieved 99.2% HPLC purity

BioResearch GmbH (Germany):

• Application: Radioligand synthesis
• Quantity: 500g custom synthesis
• Result: Successful ¹⁸F labeling efficiency (82%)

6. Technical Consultation & Quotation

Request custom synthesis quotes or technical documents:

Email: info@vivalr.com

Phone: (86) 15866781826

Provide:

• Required quantity
• Purity specifications
• Application context